Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 20/20 | 0.54 |
| ▸ | HCRTR2 | O43614 | 17/20 | 0.54 |
| ▸ | TSPO | P30536 | 1/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.42 |
| ▸ | HTR2B | P41595 | 1/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4547534 | 0.83 | HCRTR1 (0.65) | HCRTR1HCRTR2TSPOOPRK1HTR2B | |
| SCHEMBL4547533 | 0.83 | HCRTR1 (0.77) | HCRTR1HCRTR2 | |
| SCHEMBL954049 | 0.73 | CYP3A4 (0.61) | HCRTR1HCRTR2 | |
| SCHEMBL5024328 | 0.73 | HCRTR1 (0.69) | HCRTR1HCRTR2 | |
| SCHEMBL951140 | 0.72 | CYP3A4 (0.62) | HCRTR1HCRTR2 | |
| SCHEMBL1596399 | 0.71 | HCRTR1 (0.65) | HCRTR1HCRTR2 | |
| SCHEMBL1597859 | 0.71 | HCRTR1 (0.65) | HCRTR1HCRTR2 | |
| SCHEMBL933525 | 0.71 | CYP3A4 (0.62) | HCRTR1HCRTR2 | |
| SCHEMBL933952 | 0.71 | CYP3A4 (0.62) | HCRTR1HCRTR2 | |
| SCHEMBL934640 | 0.71 | HCRTR1 (0.68) | HCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011006960-A1 | SPIRO AMINO COMPOUNDS SUITABLE FOR THE TREATMENT OF INTER ALIA SLEEP DISORDERS AND DRUG ADDICTION | ROTTAPHARM S.P.A. (IT) | 2011-01-20 | — | — | WO | disclosed |
| EP-2275421-A1 | Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction | Rottapharm S.p.A. (IT) | 2011-01-19 | — | — | EP | disclosed |